From Lab to Market: The Messy, Unfiltered Story of Our AI-Powered Medical Device

Published 2024-04-28 · Updated 2026-05-23 · 6 min read · AI in Healthcare · By Sahin Boydas

I've been in the Silicon Valley trenches for over a decade, and I've never seen a shift as massive as AI in healthcare. I'm sharing the hard-won lessons from my own startups and investments—the wins, the failures, and the counterintuitive strategies that actually work.

I've been wrong about from lab to market: the messy, unfiltered story more times than I'd like to admit. But the last mistake taught me something I can't unlearn.

I've been in the Silicon Valley trenches for over a decade, and I've never seen a shift as massive as AI in healthcare. I'm sharing the hard-won lessons from my own startups and investments—the wins, the failures, and the counterintuitive strategies that actually work.

The Reality Nobody Talks About

Most people approach from lab to market: the messy, unfiltered story with assumptions that made sense five years ago. The world has moved on. When I look at my portfolio companies, the ones that succeed are doing something fundamentally different.

The first thing to understand is that simplicity beats complexity every time. I've seen this play out across dozens of companies. The pattern is unmistakable.

At RemoteTeam, we learned this the hard way. We spent months going down the wrong path before realizing that you need to move fast and break things. Once we made the switch, everything changed.

The Counterintuitive Truth

Here's what surprised me most about from lab to market: the messy, unfiltered story: the best practitioners do less, not more.

When I was building MovieLaLa, we tried to do everything at once. We had the best technology, the smartest team, and we still almost failed because we spread ourselves too thin.

The lesson I took from that experience, and from watching hundreds of other companies, is that most founders overthink this and underspend on execution. It sounds simple. It's incredibly hard to execute.

Real Talk: What Actually Matters

I'm going to cut through the noise and tell you what actually matters when it comes to from lab to market: the messy, unfiltered story.

First, execution speed beats perfection. Every time. I've never seen a company fail because they moved too fast on from lab to market: the messy, unfiltered story. I've seen plenty fail because they moved too slow.

Second, measure everything. If you can't measure it, you can't improve it. Set up tracking from day one, even if it's basic.

Third, talk to your users. This sounds obvious but you'd be amazed how many founders build their from lab to market: the messy, unfiltered story strategy in a vacuum. Get out of the building. Talk to real people.

This connects to broader themes around medical AI, clinical AI, AI mental health, biotech AI that I've been thinking about a lot lately.

What's Next

The world of from lab to market: the messy, unfiltered story is moving fast. What worked last year might not work next year. That's both the challenge and the opportunity.

My advice: stay curious, stay humble, and stay close to the people who are actually doing the work. Read less thought leadership and do more experiments. Talk to fewer consultants and more practitioners.

And if you're a founder building in this space, remember that the best time to get from lab to market: the messy, unfiltered story right is before you need to. Don't wait for a crisis to force your hand.

I'll keep sharing what I learn. This stuff matters too much to keep to myself.

Frequently Asked Questions

How can I apply this thinking to my own situation?

Start by identifying the core principle behind the opinion, not the specific example. Then ask yourself: does this principle apply to my context? If yes, test it in a small, low-risk way before going all in.

What experience informs this perspective?

This perspective comes from over a decade of building companies in Silicon Valley, two successful exits (RemoteTeam to Gusto, MovieLaLa to Gfycat), and investing in 200+ startups including Anthropic, OpenAI, and Scale AI. I write about what I've lived.

Do all experts agree with this view?

No, and that's fine. The best ideas in business are often contrarian. I share my perspective based on my experience and data, but I encourage you to seek out opposing viewpoints and form your own conclusions.

What's the most common pushback you get on this?

People often push back by citing exceptions or edge cases. And they're usually right that exceptions exist. But building a strategy around exceptions rather than patterns is a losing game for most founders.

More in AI in Healthcare

All AI in Healthcare articles · Sahin's angel investments · Startups he founded